U.S. biotech stocks win back investors in big July run

NEW YORK, July 28 (Reuters) - Biotech returned to the good graces of investors this month and it may be the beginning of a revival for stocks in the industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.